"Lebrikizumab Clears Eczema Skin Rapidly, Safely" - Kevin Kunzmann
Novel monoclonal antibody lebrikizumab was shown to significantly benefit adults with moderate to severe atopic dermatitis (eczema) in new phase 2b data evidencing the interleukin 13 (IL-13)-targeting therapy.

Press Release
Mount Sinai Dermatologists Use Tape Strips to Map Immune Changes in Common Skin Disease
Jun 10, 2025 View All Press Releases
Press Release
Mount Sinai Experts Author Landmark ‘Seminar’ on Atopic Dermatitis (Eczema) in The Lancet
Feb 13, 2025 View All Press Releases